Grogan Jane
Biogen Inc · Head of Research
Grogan Jane is listed in public filings as officer: Head of Research. This Grogan Jane insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Biogen Inc (BIIB). Investors use Grogan Jane's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --8.5k shares | Grant / ExerciseFeb 13, 2026 | Disclosure amount unavailable8.5k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --1.4k shares | Grant / ExerciseFeb 6, 2026 | Disclosure amount unavailable1.4k shares | -- | -- | |
| --3.7k shares | Grant / ExerciseFeb 6, 2026 | Disclosure amount unavailable1.9k shares | -- | -- | |
| $816k4.1k shares | Grant / ExerciseFeb 6, 2026 | $117.5K584 shares | $201.18 | -- | |
| $557k2.8k shares | Grant / ExerciseFeb 6, 2026 | $81.9K407 shares | $201.18 | -- | |
| --695 shares | Grant / ExerciseOct 31, 2025 | Disclosure amount unavailable695 shares | -- | -- | |
| $276k1.8k shares | Grant / ExerciseOct 31, 2025 | $52.0K337 shares | $154.27 | -- | |
| --1.9k shares | Grant / ExerciseFeb 7, 2025 | Disclosure amount unavailable1.4k shares | -- | -- | |
| $203k1.4k shares | Grant / ExerciseFeb 7, 2025 | $62.6K443 shares | $141.35 | -- | |
| --5.6k shares | Grant / ExerciseFeb 6, 2025 | Disclosure amount unavailable5.6k shares | -- | -- | |
| --695 shares | Grant / ExerciseNov 1, 2024 | Disclosure amount unavailable695 shares | -- | -- | |
| $85k491 shares | Grant / ExerciseNov 1, 2024 | $35.5K204 shares | $173.79 | -- |